Seeing Is Believing
KemPharm's activity chart (see below) currently has 23 price targets and 15 ratings on display.
Analysts average stock forecasts to be materialized ratio is 35.97% with an average time for these price targets to be met of 147.25 days.
Most recent stock forecast was given by from CANACCORD on 10-Nov-2022. First documented stock forecast 06-May-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Sep-2022
$19
$14.03 (282.29%)
$20
3 years 11 months 10 days ago
(10-Nov-2022)
0/2 (0%)
$14.39 (312.15%)
Buy Since 01-Feb-2022
$10
$5.03 (101.21%)
$11
4 years 2 months 3 days ago
(17-Aug-2022)
3/6 (50%)
$4.64 (86.57%)
121
Buy Since 25-Jan-2021
$28
$23.03 (463.38%)
$28
5 years 4 months 24 days ago
(26-May-2021)
0/2 (0%)
$18.14 (183.98%)
Buy Since 05-Sep-2019
$28
$23.03 (463.38%)
$4
5 years 8 months 25 days ago
(25-Jan-2021)
2/3 (66.67%)
$20.47 (271.85%)
198
$48
$43.03 (865.79%)
$160
7 years 4 months 27 days ago
(23-May-2019)
0/4 (0%)
$20.96 (77.51%)
What is KMPH (KemPharm) average time for price targets to be met?
Which analyst most recently updated their price target on KMPH (KemPharm)?
Which analyst has the most public recommendations on KMPH (KemPharm)?
Which analyst is the currently most bullish on KMPH (KemPharm)?
Which analyst is the currently most reserved on KMPH (KemPharm)?